Patient-derived xenograft models enable researchers to explore novel therapies and diagnostic tools within the context of specific mutational signatures, treatment histories, and more
By using 3D mini tumor models that closely resemble a patient's tumor, treatments could be tailored more effectively, paving the way for more personalized cancer treatments
Join Today's Clinical Lab and Dr. El Khatib to explore the determination of copy numbers in inherited disorders using MLPA and capillary electrophoresis
Sanford Burnham Prebys Medical Discovery Institute
MASH is expected to surpass hepatitis C as the main cause of liver transplantation in the US
We’ve updated our Privacy Policy to make it clearer how we use your personal data. Please read our Cookie Policy to learn how we use cookies to provide you with a better experience.